131 related articles for article (PubMed ID: 11604505)
1. Identification of a role for the sialomucin CD164 in myogenic differentiation by signal sequence trapping in yeast.
Lee YN; Kang JS; Krauss RS
Mol Cell Biol; 2001 Nov; 21(22):7696-706. PubMed ID: 11604505
[TBL] [Abstract][Full Text] [Related]
2. CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor.
Doyonnas R; Yi-Hsin Chan J; Butler LH; Rappold I; Lee-Prudhoe JE; Zannettino AC; Simmons PJ; Bühring HJ; Levesque JP; Watt SM
J Immunol; 2000 Jul; 165(2):840-51. PubMed ID: 10878358
[TBL] [Abstract][Full Text] [Related]
3. Epitope recognition of antibodies that define the sialomucin, endolyn (CD164), a negative regulator of haematopoiesis.
Jorgensen-Tye B; Levesque JP; Royle L; Doyonnas R; Chan JY; Dwek RA; Rudd PM; Harvey DJ; Simmons PJ; Watt SM
Tissue Antigens; 2005 Mar; 65(3):220-39. PubMed ID: 15730515
[TBL] [Abstract][Full Text] [Related]
4. CD164--a novel sialomucin on CD34+ cells.
Watt SM; Chan JY
Leuk Lymphoma; 2000 Mar; 37(1-2):1-25. PubMed ID: 10721766
[TBL] [Abstract][Full Text] [Related]
5. Genomic analysis of a murine cell-surface sialomucin, MGC-24/CD164.
Kurosawa N; Kanemitsu Y; Matsui T; Shimada K; Ishihama H; Muramatsu T
Eur J Biochem; 1999 Oct; 265(1):466-72. PubMed ID: 10491205
[TBL] [Abstract][Full Text] [Related]
6. CD164.
Zannettino AC
J Biol Regul Homeost Agents; 2001; 15(4):394-6. PubMed ID: 11862985
[No Abstract] [Full Text] [Related]
7. Relationship between novel isoforms, functionally important domains, and subcellular distribution of CD164/endolyn.
Chan JY; Lee-Prudhoe JE; Jorgensen B; Ihrke G; Doyonnas R; Zannettino AC; Buckle VJ; Ward CJ; Simmons PJ; Watt SM
J Biol Chem; 2001 Jan; 276(3):2139-52. PubMed ID: 11027692
[TBL] [Abstract][Full Text] [Related]
8. Regulation of myoblast motility and fusion by the CXCR4-associated sialomucin, CD164.
Bae GU; Gaio U; Yang YJ; Lee HJ; Kang JS; Krauss RS
J Biol Chem; 2008 Mar; 283(13):8301-9. PubMed ID: 18227060
[TBL] [Abstract][Full Text] [Related]
9. The ratio of splicing variants of MGC-24/CD164, a sialomucin, correlates with the metastatic potential of colorectal carcinomas.
Matsui T; Kurosawa N; Hibi K; Akiyama S; Kasai Y; Sakamoto J; Ito K; Nakao A; Muramatsu T
J Biochem; 2000 Jun; 127(6):1103-7. PubMed ID: 10833281
[TBL] [Abstract][Full Text] [Related]
10. Functionally defined CD164 epitopes are expressed on CD34(+) cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues.
Watt SM; Butler LH; Tavian M; Bühring HJ; Rappold I; Simmons PJ; Zannettino AC; Buck D; Fuchs A; Doyonnas R; Chan JY; Levesque JP; Peault B; Roxanis I
Blood; 2000 May; 95(10):3113-24. PubMed ID: 10807777
[TBL] [Abstract][Full Text] [Related]
11. Colocalization analysis of sialomucins CD34 and CD164.
McGuckin CP; Forraz N; Baradez MO; Lojo-Rial C; Wertheim D; Whiting K; Watt SM; Pettengell R
Stem Cells; 2003; 21(2):162-70. PubMed ID: 12634412
[TBL] [Abstract][Full Text] [Related]
12. Mucin-like molecules as modulators of the survival and proliferation of primitive hematopoietic cells.
Simmons PJ; Levesque JP; Haylock DN
Ann N Y Acad Sci; 2001 Jun; 938():196-206; discussion 206-7. PubMed ID: 11458509
[TBL] [Abstract][Full Text] [Related]
13. Endolyn is a mucin-like type I membrane protein targeted to lysosomes by its cytoplasmic tail.
Ihrke G; Gray SR; Luzio JP
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):287-96. PubMed ID: 10620506
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate antigens expressed on stem cells and early embryonic cells.
Muramatsu T; Muramatsu H
Glycoconj J; 2004; 21(1-2):41-5. PubMed ID: 15467397
[TBL] [Abstract][Full Text] [Related]
15. Stem cell antigen-1 is necessary for cell-cycle withdrawal and myoblast differentiation in C2C12 cells.
Epting CL; López JE; Shen X; Liu L; Bristow J; Bernstein HS
J Cell Sci; 2004 Dec; 117(Pt 25):6185-95. PubMed ID: 15546912
[TBL] [Abstract][Full Text] [Related]
16. MmNEU3 sialidase over-expression in C2C12 myoblasts delays differentiation and induces hypertrophic myotube formation.
Papini N; Anastasia L; Tringali C; Dileo L; Carubelli I; Sampaolesi M; Monti E; Tettamanti G; Venerando B
J Cell Biochem; 2012 Sep; 113(9):2967-78. PubMed ID: 22552967
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting CD164 expression in colon cancer cell line HCT116 leads to reduced cancer cell proliferation, mobility, and metastasis in vitro and in vivo.
Tang J; Zhang L; She X; Zhou G; Yu F; Xiang J; Li G
Cancer Invest; 2012 Jun; 30(5):380-9. PubMed ID: 22409183
[TBL] [Abstract][Full Text] [Related]
18. SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or alpha 7 integrin during muscle development.
Haider SR; Wang W; Kaufman SJ
Exp Cell Res; 1994 Feb; 210(2):278-86. PubMed ID: 7507852
[TBL] [Abstract][Full Text] [Related]
19. ErbB3 binding protein-1 (Ebp1) controls proliferation and myogenic differentiation of muscle stem cells.
Figeac N; Serralbo O; Marcelle C; Zammit PS
Dev Biol; 2014 Feb; 386(1):135-51. PubMed ID: 24275324
[TBL] [Abstract][Full Text] [Related]
20. Adhesion receptors as regulators of the hematopoietic process.
Verfaillie CM
Blood; 1998 Oct; 92(8):2609-12. PubMed ID: 9763542
[No Abstract] [Full Text] [Related]
[Next] [New Search]
